Eating fish may prevent hearing loss

Research indicates that eating two or more servings of fish per week reduces the risk of hearing loss in women

fish-422543-640

Eating fish daily reduces hearing loss by 20 percent

A new study published in the American Journal of Clinical Nutrition highlighted that two or more servings of fish per week could lower the risk of acquired hearing loss. A two decade long research conducted on 65,215 participants suggested that consumption of fish and higher intake of omega-3 fatty acids improved cochlear blood flow.

Dr Sharon Curhan, study author, said, "These findings suggested that diet may play an important role in preventing acquired hearing loss." She added that women who consumed fish at least twice per week, demonstrated a 20 percent lowered risk of developing hearing loss than women who seldom ate fish.

Dr Curhan explained that acquired hearing loss is a highly prevalent condition among women, which ultimately leads to chronic health disability. Though decline in hearing is considered to be an inevitable aspect of aging, the onset could be delayed by increasing the consumption of omega-3 fatty acids, she added.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy

Saturday, 25 Feb 2017   |   Celgene

Business Wire India Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:

Piramal Enterprises Limited and Ivanhoé Cambridge Announce Partnership

Thursday, 23 Feb 2017   |   Piramal Enterprises Limited

Business Wire India Ivanhoé Cambridge to allocate an initial US$250m PEL will co-invest between

Bangalore-based Start-up, Cardiotrack, a Fast Growing Predictive Diagnostic

Wednesday, 22 Feb 2017   |   Cardiotrack

Business Wire India Bangalore-based start-up, Cardiotrack, which provides best-in-class predictive diagnosis

BusinessWire India.com - Pharmaceutical

Bwi-logo

REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy

Saturday, 25 Feb 2017   |   Celgene

Business Wire India Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:

Piramal Enterprises Limited and Ivanhoé Cambridge Announce Partnership

Thursday, 23 Feb 2017   |   Piramal Enterprises Limited

Business Wire India Ivanhoé Cambridge to allocate an initial US$250m PEL will co-invest between

BusinessWire India.com - Medical Devices

Bwi-logo

REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy

Saturday, 25 Feb 2017   |   Celgene

Business Wire India Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:

Bangalore-based Start-up, Cardiotrack, a Fast Growing Predictive Diagnostic

Wednesday, 22 Feb 2017   |   Cardiotrack

Business Wire India Bangalore-based start-up, Cardiotrack, which provides best-in-class predictive diagnosis

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email

X